Stock BDSX BIODESIX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Biodesix, Inc.

Equities

BDSX

US09075X1081

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
1.37 USD +3.40% Intraday chart for Biodesix, Inc. 0.00% -25.54%
May. 21 Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting CI
May. 13 TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biodesix to Participate in Two Investor Conferences in June
BU
Biodesix to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting
AQ
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
BU
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
BU
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
BU
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
BU
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
BU
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
AQ
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
BU
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
BU
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
AQ
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
BU
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
BU
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
BU
Biodesix : New Financial Obligation - Form 8-K
PU
Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method
AQ
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
BU
Biodesix to Participate in Two Upcoming Investor Conferences in November
BU
 Biodesix Announces Third Quarter 2023 Results and Highlights
BU
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BDSX Stock
  4. News Biodesix, Inc.
  5. Press Releases